Guidewires Market Size & Share 2025 – 2034

Guidewires Market Size

The global guidewires market was estimated at USD 1.3 billion in 2024. The market is expected to grow from USD 1.4 billion in 2025 to USD 2.3 billion in 2034, at a CAGR of 5.7% during the forecast period, according to the latest report published by Global Market Insights Inc. The guidewires market is driven by a growing geriatric population base, increasing number of lifestyle disorders, favorable reimbursement policies in developed countries, rising prevalence of cardiovascular diseases, and technological advancements in guidewire design, among other contributing factors.
 

Expansion of healthcare infrastructure in emerging markets, increasing use of neurovascular interventions, and development of bioresorbable and smart guidewires are among the key factors propelling the product demand. Boston Scientific, ASAHI INTECC, Terumo, Abbott, and Medtronic are among the leading players operating in the market. These players mainly focus on geographic expansion, product innovation, collaboration with local or regional healthcare providers, and a wide range of product portfolios for different indications, among others.
 

The market has increased from USD 1.1 billion in 2021 to USD 1.2 billion in 2023, with the historic growth rate of 8.3%. The healthcare sector is moving from open surgeries toward less invasive surgical methods, which is expected to contribute substantially to the market growth. Procedures such as PCI (Percutaneous Coronary Intervention), endovascular therapy, and neurovascular interventions have less trauma associated with them, require shorter hospital stays, and provide quicker recoveries than traditional open surgeries. Guidewires play an important role in allowing physicians to navigate vascular structures with precision during these procedures. For example, according to the recently reported data, the U.S. records around >600,000 PCI procedures per year, highlighting the importance of catheter-based therapies for treating coronary artery disease.
 

Additionally, the rise in the number of lifestyle-related disorders in developing countries is among the key contributors to the high growth of the guidewire industry. The rapid increase in urbanization, sedentary lifestyles, and transitioning to a diet that has been primarily made up of processed foods have led to a significant increase in the number of people suffering from chronic diseases such as diabetes, high blood pressure, and obesity. These chronic diseases push the people suffering with these conditions towards cardiovascular and peripheral vascular disease, resulting in increased product demand.
 

Further, in developed economies, the reimbursement structure supports the adoption of guidewires and other intervention procedures. Hospitals and other healthcare settings have a considerable financial incentive to implement and promote minimally invasive techniques through different interventional procedures such as PCI, endovascular therapy, and neurovascular interventions, which are dependent on the use of guidewire technology. Furthermore, the move towards Bundle Payment Models (BPM) and Value-Based Care Programs (VBC) also incentivizes using quality guidewires with the potential to decrease complications and increase success rates.
 

Guidewires are thin, flexible medical devices used to navigate blood vessels, ducts, or other pathways during minimally invasive procedures. They serve as a guide for catheters, stents, or other instruments, ensuring precise placement while minimizing trauma. Guidewires vary in material, coating, and design for specific vascular or interventional applications.
 

Guidewires Market Trends

Partnerships between manufacturers and hospitals, growing demand in emerging economies, increasing demand for minimally invasive procedures and rising number of interventional radiology procedures are among the key trends fueling the market growth.
 

• There is a consistent rise in guidewires market growth with an increasing number of patients suffering from cardiovascular, peripheral vascular and neurovascular diseases globally coupled with the increase in lifestyle associated disease such as type II diabetes, hypertension and obesity among other conditions. Such diseases lead to a greater need for the use of minimally invasive procedures thereby increasing the adoption of guidewires.
   
• With advances in technology such as hydrophilic coatings, improvements in torque-control and increased steerability, guidewires provide greater accuracy when performing medical procedures and increase the range of possibilities for clinical applications. The growing preference for minimally invasive surgeries with faster recovery times and reduced risk of complications, further supports the expansion of the market for guidewires.
   
• Furthermore, the high number of interventional cardiology and radiology procedures being performed, as a result of growing elderly population may further push the product demand and market expansion. Investment into healthcare systems, particularly in emerging countries, is enabling greater access to advanced interventional devices. In addition, the development of affordable hybrid guidewires and the expansion of many major manufacturers to provide more comprehensive product lines are strengthening clinical acceptance and market growth.
   

Guidewires Market Analysis

In 2021, the market was valued at USD 1.05 billion and grew to USD 1.14 billion in 2022, reaching USD 1.23 billion by 2023. Rising trend of outpatient procedures and supportive government initiatives to improve cardiac care are among the key variables contributing to industry growth.
 

Based on material, the global guidewires market is segmented into nitinol, stainless steel, hybrid and other materials. The nitinol segment accounted for a leading share of 46.3% in 2024. Favorable reimbursement policies in developed countries is anticipated to fuel the segmental growth. The segment is expected to reach USD 1.1 billion by 2034, growing at a CAGR of 5.9% during the forecast period.
 

• The nitinol segment accounted for the leading share in the market, as it has superior material properties that are necessary in complex cardiovascular, peripheral, and neurovascular procedures. The nitinol segment provides enhanced flexibility and kink resistance due to its unique shape-memory and super-elastic properties, allowing clinicians to navigate the tortuous vessels with greater accuracy and safety.
   
• These characteristics reduce complications during procedures and enhance clinical outcomes, resulting in extensive use of nitinol-based guidewires. In addition, nitinol provides increased durability and fatigue resistance, allowing for multiple cycles of stress during complicated interventions without decreasing their effectiveness.
   
• In addition, the increasing incidence of chronic illnesses such as coronary artery disease, peripheral artery disease, and stroke are further driving up the demand for nitinol-based guidewires. Minimally invasive procedures for these conditions require precision and reliability, which make nitinol-based guidewires the preferred choice.
   
• Further, the stainless steel segment held a revenue of USD 437.5 million in 2024, with projections indicating a steady expansion at 5.3% CAGR from 2025 to 2034. In interventional devices, stainless steel guidewires have always been a vital component because of their high tensile strength, torque control, and predictable performance.
   
• Moreover, due to product characteristics such as rigidity and durability, they are best suited for providing access to blood vessels and delivering devices. While nitinol provides super elastic properties, stainless steel has greater column strength, which enables clinicians to advance catheters and sheaths through difficult-to-reach or calcified blood vessels.
   

Based on coating, the guidewires market is segmented into coated and non-coated. The coated segment accounted for a dominating share of 89.3% in 2024.
 

• Due to its favorable clinical characteristics and increasing use in an expanding number of interventional implantations, the coated segment is expected to continue its domination throughout the forecast period.
   
• Many coating technologies are commonly used, including hydrophilic (water-attracting) and anti-thrombogenic (to prevent clotting) and/or heparin-based, hydrophobic (water-resistant), and silicone-based coatings, which are becoming more prevalent in clinical practice.
   
• These types of guidewires provide increased lubricant properties, decreased friction, and substantial trackability. Therefore, these types of guidewires allow interventional physicians to more accurately and safely navigate through the complex anatomy of the peripheral vascular system.
   
• Additionally, the increasing need for minimally invasive procedures such as angioplasty, neurovascular interventions, and urological procedures has led to an increased need for coated guidewires to facilitate patient care and enhance the quality and efficiency of procedural outcomes.
   
• Further, advancements in coating technologies, such as next-generation hydrophilic polymers and durable biocompatible coatings, have increased product reliability and reduced procedural complications.
   
• Furthermore, the non-coated segment held a revenue of USD 141.4 million in 2024, with projections indicating a steady expansion at 4.1% CAGR from 2025 to 2034. Traditional guidewire technologies are represented by non-coated guidewires, which fulfill the basic requirements of a variety of interventional procedural applications while also providing exceptional durability and reliability as a result of their simplicity.
   
• In contrast to coated guidewires, non-coated guidewires lack surface modifications, including hydrophilic or hydrophobic layers or anti-thrombotic coating. They achieve strength, torque control, and predictable operating characteristics through the inherent properties of the base material from which they are manufactured.
   
• Moreover, non-coated guidewires are particularly indicated for procedures that are short, have immediate vascular access requirements, and where there are very low levels of friction. Hence, non-coated guidewires are commonly used in standard diagnostic angiography, basic catheter placement, and various urological interventions due to their value, ease of use, and cost-effectiveness.
   

Based on application, the guidewires market is segmented into coronary guidewires, peripheral guidewires, urology guidewires, neurovascular guidewires, and other applications. The coronary guidewires segment accounted for a leading share and was valued at USD 557 million in 2024.
 

• The number of patients treated using percutaneous coronary interventions (PCI) is on the rise due to the increasing number of people suffering from coronary artery disease (CAD) caused by an aging population, a lack of exercise, diabetes, and/or hypertension. The large volume of PCI procedures results in a growing demand for coronary guidewires.
   
• The introduction of new technologies used in minimally invasive cardiac procedures has helped to speed up the recovery time from these procedures and decrease the risk of complications. The latest developments in the field include innovations in the torque control of guidewires, hydrophilic and hydrophobic coatings applied to the guidewires, flexibility of the tips, and the steerability of the guidewires, which have further enhanced the effectiveness of these guidewires on complex lesions such as chronic total occlusions (CTOs).
   
• In addition, the growth in investments in laboratory infrastructure at hospitals and outpatient surgery centers has enabled an increase in the total number of procedures performed with coronary guidewires. The growth in doctor preference for the use of advanced guidewires (e.g., polymer-jacketed guidewires) and increase in reimbursement for PCI also contribute to the ongoing dominance of this segment of the market.
   
• The peripheral guidewire segment is expected to record the fastest growth with a CAGR of 6.2% over the forecast period. The peripheral guidewires market is expanding rapidly, stimulated by the growing prevalence of peripheral artery disease (PAD), which affects people globally due to aging populations and lifestyle-related risk factors.  According to Science Partner Journals, the number of PAD cases globally will increase by 220% by 2050, reaching a staggering 360 million.
   
• Moreover, endovascular intervention is the standard method of PAD treatments mentioned by NIH, replacing the traditional open surgeries, which is escalating demand for guidewires that offer superior trackability and support in long, tortuous peripheral vessels.
   
• The urology guidewires segment held a revenue of USD 166 million in 2024, with projections indicating a steady expansion at 4.8% CAGR from 2025 to 2034. The market is stimulated by the rising incidence of urological disorders and the global preference for minimally invasive procedures in urinary tract interventions. According to NIH, there are more than 404.61 million cases, which is stimulating the market demand.
   
• Moreover, the increasing prevalence of urolithiasis (kidney stones), affecting the global population, is a major driver for guidewires used in stone removal and ureteroscopy procedures. According to NIH, the incidence of urolithiasis increased by 48.57%, from 77.78 million incident cases in 1990 to 115.55 million in 2019, further stimulating the market demand.
   

Based on diameter, the guidewires market is segmented into 0.014-inch, 0.018-inch, 0.025-inch, 0.032-inch, 0.035 inch, and 0.038 inch. The 0.014-inch segment accounted for a majority share of 47.9% in 2024.
 

• The wide acceptance of 0.014-inch guidewires for use in minimally invasive cardiovascular and peripheral vascular procedures is projected to drive growth in this market segment. The 0.014-inch guidewire is extremely flexible and well-tracked, providing the ideal solution for navigating small, tortuous, and severely stenotic vessels during coronary angioplasty and complex PCI procedures. This compatibility with a great variety of microcatheters, balloons, and stents enhances these procedures efficiency and accuracy due to their relatively large size compared with smaller gauge guidewires.
   
• Additionally, the continual development of new technologies to enhance guidewire performance, such as hydrophilic and hybrid coatings, which increase lubricity, decrease friction, and allow for smoother device delivery, further pushes the demand for this segment of guidewires.
   
• The 0.018-inch segment held a revenue of USD 203.8 million in 2024, with projections indicating a steady expansion at 5.9% CAGR from 2025 to 2034. As physicians increasingly perform intricate peripheral vascular interventions that necessitate extra support and stability, the 0.018-inch guidewire size has been increasingly preferred. The preference for 0.018-inch guidewires is because they provide more shaft strength and push ability than smaller diameter wires when used on long calcified lesions or chronic total occlusions of the femoropopliteal or infrapopliteal arterial systems.
   
• The 0.035 segment held a revenue of USD 274.2 million in 2024, with projections indicating a steady expansion at 5.3% CAGR from 2025 to 2034. The 0.035-inch guidewires are used for large-bore vascular procedures such as EVAR and TAVR because they provide unmatched shaft strength and stability for delivering bulky stent grafts and introducer sheaths. For instance, Cook Medical’s Amplatz Super Stiff 0.035-inch wire is widely used in these cases, offering exceptional rigidity to maintain position during complex endovascular repairs.
   
• Moreover, they are critical in trauma and emergency interventions where rapid vascular access and secure tract maintenance are essential for life-saving device placement.
   

Based on length, the guidewires market is segmented into 80 – 145 cm, 150 -200 cm, 210 - 300 cm, and above 305 cm. The 150 -200 cm segment accounted for a leading share and was valued at USD 529.6 million in 2024.
 

• Guidewires in the 150–200 cm category, most notably 150 cm and 180 cm, are essential in specialized gastrointestinal, biliary, and hepatopancreatic procedures, especially ERCP. These guidewire lengths are classified as short-wire-type endoscopic guidewires and are designed for those cases when the endoscopist needs to maintain direct control of the guidewire from within the scope itself to enhance the efficacy during cannulation and advancing any devices through the working channel of the endoscope during an ERCP. The important feature of being able to make rapid exchanges of accessories such as sphincterotomes, stone retrieval balloons, and stent delivery systems during an ERCP with the use of a 150-200 cm guidewire is an effective way to save time and reduce patient exposure to fluoroscopy in the long run.
   
• In addition, there has been a significant increase in the number of people diagnosed globally with choledocholithiasis (common bile duct stones), biliary strictures, and disorders of the pancreatic duct. This increase in demand is driving the growth of this segment within the industry.
   
• Additionally, the 210–300 cm guidewire segment was valued at USD 447.3 million in 2024. The 210–300 cm guidewire segment is widely used in exchange-length procedures across coronary, peripheral, neurovascular, and structural heart interventions. This range of lengths facilitates the exchange of large catheter and balloon systems and stent devices without losing vascular access during complex angioplasty, EVT, CTO recanalization, and multiple device navigation procedures.
   
• Furthermore, guidewires above 300 cm, typically 350 cm and longer, are essential for complex exchanges and advanced endovascular interventions, particularly in peripheral, structural heart, and hybrid vascular procedures.
   
• They help facilitate continued access retention during device withdrawal replacement procedures over long distances between sites of entry points.
   
• Moreover, the length of ultra-long wires is expected to allow their usage in iliac-femoral, SFA revascularization, thoracoabdominal, and other procedures requiring the use of multiple device types.
   

Based on end use, the guidewires market is segmented into hospitals, ambulatory surgical centers, and other end users. The hospitals segment accounted for the leading market share of 77.3% in 2024 as it records high patient footfall including both public and private hospital settings.
 

• Hospitals represent the largest segment of the guidewire market, as several driving forces within the hospital environment influence both the growth in product usage and the adoption of innovative interventional technology. As hospitals are the primary sites for many of the complicated cardiovascular, neurovascular, and peripheral vascular surgical interventions, there has been a consistent and growing need for highly accurate guidewires.
   
• The increasing prevalence of chronic illnesses, including coronary artery disease, stroke, and PAD (peripheral artery disease), has significantly increased the number of diagnostic/therapeutic intervention procedures performed, thereby contributing to overall use of the products.
   
• In addition, hospital settings have a significant advantage of having interventional cardiologists, radiologists, and vascular surgeons, who are trained to perform these complicated procedures with near-perfect precision and utilize guidewires for minimally invasive surgeries performed within the hospital environment.
   
• The ASC segment is anticipated to record higher growth with a 6.6% CAGR over the analysis period. The transition to outpatient treatment due to affordable and convenient medical assistance has made ambulatory surgical centers the fastest-growing end-user section of the guidewire industry. ASCs reduce time or the need for long hospital stays and lower the costs associated with procedures, reducing recovery time and care, thus becoming the preferred choice for all types of MIS procedures such as PCI, PVDs (peripheral vascular devices), etc.
   
• Increased investment from payers to transition to the outpatient environment and a rise in the percentage of insurance coverage and healthcare expenditure have helped facilitate rapid growth in the ASC space.
   
• Furthermore, the development of ASCs is witnessing rapid growth in many of the developing countries globally with government support and private investments. Ambulatory surgical centers are anticipated to continue to grow as they record increased volumes of procedures being performed and a growing demand for interventional devices in addition to supporting guidewire market growth.
   

North America Guidewires Market

North America market accounted for majority share of 37.7% in 2024 in the guidewires market and is anticipated to show notable growth over the forecast period.
 

• The regional growth is supported by advanced healthcare infrastructure, high procedure volumes, strong adoption of minimally invasive interventions, and continuous technological innovation.
   
• The region has one of the highest incidences of cardiovascular diseases, peripheral artery disease, neurovascular disorders, and urological conditions, all of which rely heavily on guidewires for diagnostic and therapeutic procedures. For instance, according to CDC 2024, in the U.S. heart disease is the leading cause of death for men, women. One person dies every 34 seconds from cardiovascular disease. In 2023, 919,032 people died from cardiovascular disease. That's the equivalent of 1 in every 3 deaths.
   
• The growing prevalence of obesity, diabetes, and aging-related vascular complications further fuels the need for angioplasty, stenting, embolization, and endoscopic procedures, driving steady demand for high-precision guidewires.
   

The U.S. guidewires market was valued at USD 379.6 million and USD 408.1 million in 2021 and 2022, respectively. In 2024 the market size was valued at USD 465.5 million from USD 437.2 million in 2023. The high procedural volume along with supportive reimbursement policies in the country is projected to fuel the market growth.
 

• Due to the presence of established catheterization laboratories, hybrid operating rooms, and advanced neuro-interventional facilities within the U.S., there is a consistent demand for next-generation guidewires that provide improved torque control, steerability, and lubricity.
   
• In addition, hospitals and ambulatory surgical centers in the country have established strong reimbursement models for minimally invasive surgery (MIS) procedures, resulting in the widespread usage of guidewires across healthcare settings. Additionally, with significant ongoing investments by healthcare providers in the digital space of healthcare, factors such as robotic-assisted and image-guided surgery are also expected to propel the demand for specialized guidewires for complex interventions.
   
• Furthermore, leading manufacturers such as Boston Scientific, Abbott, Medtronic, and Terumo are continuously investing in the development of novel products and enhancing current portfolios that include cutting-edge technologies such as hydrophilic coatings, hybrid nitinol cores for both conventional and CTO procedures, and specialty wires specifically designed for complex interventions.
   
• Moreover, the rapid adoption of guidewires is also being fostered by clinical training programs that provide physicians with the skills necessary to safely and effectively utilize these advanced devices. The collaboration between manufacturers and academic medical centers allows for the sharing of quality education with practicing physicians.
   

Europe Guidewires Market

Europe accounted for a substantial share in the market and was valued at USD 341.5 million in 2024.
 

• Multiple factors promote the regional demand and also propel the technological advancement in the products. The increasing prevalence of cardiovascular disease (coronary artery disease, peripheral artery disease, and stroke) serves as a primary factor for procedure volumes to grow in both hospitals and outpatient surgical centers. For example, based on statistics from the European Union, there were approximately 1.68 million deaths in 2022 attributed to diseases of the circulatory system, representing 32.7% of total deaths in the EU.
   
• In addition, Europe's aging population has placed additional pressure on demand for complex interventional cardiology procedures such as angioplasty or neurovascular interventions in which guide wires are critical components of procedural success, thereby driving the industry's growth.
   

Germany held significant share of the European guidewires market, showcasing strong growth potential.
 

• Germany is a leading European hub for advanced medical technologies and products, including guidewires. The country’s strong healthcare infrastructure and high adoption of minimally invasive procedures drive significant demand.
   
• Cardiovascular diseases remain a major health concern, fueling interventional cardiology and neurovascular treatments. Country’s aging population further accelerates the need for guidewire-based interventions. The presence of well-established hospitals and specialized cardiac centers ensures continuous utilization of advanced devices.
   
• Additionally, favorable reimbursement policies and strict regulatory standards promote quality and innovation. Growing investments in digital health and robotic-assisted surgeries are expected to enhance guidewire integration with imaging systems, creating opportunities for premium products. The country’s overall market outlook remains robust, supported by technological advancements and a strong focus on precision medicine.
   

Asia Pacific Guidewires Market

The Asia Pacific market accounted for a significant share of the market and was valued at USD 379 million in 2024.
 

• The Asia Pacific region is expected to witness strong growth in the guidewires market over the analysis period, supported by expanding healthcare infrastructure, rising procedure volumes, and increasing adoption of advanced interventional technologies.
   
• The region’s growth is driven by a combination of demographic, clinical, and technological factors. A key driver is the rapidly aging population, which is increasing the prevalence of cardiovascular diseases, peripheral artery disease, and neurovascular disorders. Countries such as Japan, China, and India are experiencing rising elderly populations, resulting in higher demand for minimally invasive procedures like angioplasty and stent placements, which rely heavily on guidewires.
   
• Moreover, improving healthcare infrastructure in emerging economies such as India, Vietnam, and Indonesia, including the expansion of tertiary care hospitals, catheterization labs, and specialized cardiac centers, is facilitating greater accessibility and adoption of advanced guidewires. 
   

China guidewires market is estimated to grow with a robust CAGR in the Asia Pacific market.
 

• The rise in incidence of cardiovascular diseases in China is one of the key factors driving the industry growth. Increasing urbanization, more sedentary lifestyles, unhealthy diets, and surging diabetes and hypertension rates further increase the volume of procedures performed using guidewires.
   
• Additionally, the shift towards treating patients with minimally invasive procedures rather than through traditional open procedures has resulted in an increased need for high-precision guidewires. The use of modern guidewire technologies through MIS procedures ensures that patients return to normal activities sooner, have fewer complication risks, and are discharged from the hospital earlier compared to traditional open procedures.
   
• In addition, various initiatives from the government to promote and support access to cardiovascular care and the efforts of already established international manufacturers to work with local distributors are resulting in an increasing number of indications where guidewires are used, thereby fueling the market growth.
   

Latin America Guidewires Market

Brazil leads the Latin American guidewires market, exhibiting remarkable growth during the analysis period.
 

• Brazil represents the largest healthcare market in Latin America, with rising demand for interventional procedures due to increasing cardiovascular and lifestyle-related disorders. Public and private healthcare sectors are expanding in the country. The adoption of minimally invasive techniques is growing, particularly in urban regions with advanced hospitals.
   
• Government initiatives to improve cardiac care and expand universal health coverage are expected to boost product usage. Brazil’s younger population is gradually shifting toward preventive healthcare, but chronic conditions still have a significant disease burden, creating sustained demand for vascular and urologic interventions.
   
• Additionally, future growth is expected to be driven by infrastructure modernization, partnerships with global manufacturers, and training programs to address skill gaps. Integration of imaging and navigation technologies may further accelerate adoption of advanced guidewires.   
   

Middle East and Africa Guidewires Market

Saudi Arabia guidewires market to experience substantial growth in the Middle East and Africa market in 2024.
 

• Saudi Arabia’s healthcare sector is undergoing rapid transformation under Vision 2030, emphasizing modernization and advanced medical technologies. Cardiovascular diseases and diabetes are prevalent in the country, increasing the need for interventional procedures that rely on guidewires.
   
• The country is investing significantly in specialized cardiac centers and minimally invasive surgery capabilities. High purchasing power and government-backed healthcare spending support adoption of premium devices.
   
• However, skilled workforce shortages in complex interventions remain a challenge, which is being addressed through training initiatives with global players.
   
• Moreover, the private healthcare segment is expanding with robust growth, creating opportunities for global players to introduce innovative guidewire solutions in the country. Saudi Arabia’s strategic focus on quality care and technology adoption positions it as a key market for advanced guidewires.
   

Guidewires Market Share

The global guidewires market has an oligopoly structure. A few big multinational corporations primarily dominate the overall market dynamics. Leading companies such as Boston Scientific, ASAHI INTECC, Terumo, Abbott, and Medtronic are enhancing their market presence by acquiring strategically important players, partnering with new companies, developing new products, and expanding into markets experiencing a high level of growth.
 

In addition, the major players in this sector continue to focus on technological innovation with an emphasis on using advanced material technology, enhanced tip flexibility, improved steerability, and superior coating technology to meet the changing clinical needs of their clients.
 

Further, increased investment in R&D, collaboration with hospitals and catheterization laboratories, and entry into underserved markets are fundamental for increasing the global footprint of companies that manufacture guidewires. Also, companies are focusing on developing specialized coronary, peripheral, neurovascular, and urological guidewires for their various procedural needs.
 

Guidewires Market Companies

A few of the prominent players operating in the global guidewires industry include:

• Abbott Laboratories
• AngioDynamics
• ASAHI INTECC
• B. Braun SE
• Becton, Dickinson and Company
• Boston Scientific
• Cordis
• Cook Medical
• Medtronic
• Merit Medical Systems
• Olympus
• Stryker
• Teleflex
• Terumo
   
• Boston Scientific

Boston Scientific accounted for a leading market share of 20.1% in 2024. The company focuses on expanding its minimally invasive portfolio through continuous innovation, strategic acquisitions, and global market penetration. The company emphasizes digital health integration, operational efficiency, and category leadership in cardiovascular, structural heart, and neuromodulation therapies.
 

• Abbott

Abbott leverages a diversified healthcare portfolio, emphasizing diagnostics, cardiovascular devices, and consumer health. Its strategy includes innovation in wearables, AI-driven platforms, and affordability for emerging markets, supported by acquisitions and partnerships to strengthen preventive and personalized care.
 

• ASAHI INTECC

ASAHI INTECC aims to strengthen its position in high-precision guidewires and catheters by investing in R&D, robotics, and smart technologies. It prioritizes global expansion, niche leadership in neurovascular and cardiovascular interventions, and partnerships to enhance treatment outcomes.
 

Guidewires Industry News:

• In October 2025, Boston Scientific announced the global launch of its Journey Guidewire, an innovative 0.014-inch guidewire designed for challenging small vessel peripheral angioplasty procedures. This advanced design improves device delivery and performance, supporting physicians in accessing complex peripheral lesions and advancing minimally invasive vascular interventions.
   
• In February 2025, Asahi Intecc Co., Ltd. announced the launch of its ASAHI Miracle Neo 3 guidewire, designed to enhance safety and precision in complex coronary interventions. The new guidewire features a blunt tip for improved vessel protection, a hydrophilic coating for smooth navigation, and proprietary ACT ONE technology for superior torque control and maneuverability. This innovation aimed to support interventional cardiologists in treating challenging lesions with greater efficiency and reliability.
   
• In January 2025, Olympus Latin America (OLA), a subsidiary of Olympus Corporation, acquired the distribution business of Sur Medical SpA in Chile, establishing a direct presence in the Chilean medical technology market. Through this acquisition, Olympus Corporation Chile focuses on enabling more efficient distribution of the company's products and services, as Sur Medical had been Olympus’ partner since 2013 in the gastrointestinal and endotherapy product segments.
   

The guidewires market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in (USD Million) and volume (Units) from 2021 - 2034 for the following segments:

Market, By Material

• Nitinol
• Stainless steel
• Hybrid
• Other materials

Market, By Coating

• Coated
  • Hydrophilic coating
  • Anti-thrombogenic/Heparin coating
  • Hydrophobic coating
  • Silicone coating
  • Tetrafluoroethylene (TFE) coating
• Non-coated

Market, By Application

• Coronary guidewires
• Peripheral guidewires
• Urology guidewires
• Neurovascular guidewires
• Other applications

Market, By Diameter

• 0.014 inch
• 0.018 inch
• 0.025 inch
• 0.032 inch
• 0.035 inch
• 0.038 inch

Market, By Length

• 80 – 145 cm
• 150 – 200 cm
• 210 – 300 cm
• Above 305 cm

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE